DAMLECOVATEIN
UNII 26JP6N8VU6

Substance Identification & Data

This profile provides standardized clinical and technical data for Damlecovatein, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 26JP6N8VU6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3020658-23-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

26JP6N8VU6

CAS Registry Number

3020658-23-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DAMLECOVATEIN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C211718

National Cancer Institute reference terminology for clinical and research data.

INN ID

13489

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Damlecovatein. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DAMLECOVATEIN

Common Names & Synonyms

319-537-SPIKE GLYCOPROTEIN (537-GLYCINE) (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 VARIANT XBB.1.16 PRECURSOR) FUSION PROTEIN WITH 319-537-SPIKE GLYCOPROTEIN (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 VARIANT XBB.1.16 PRECURSOR)

DAMLECOVATEIN [INN]

DAMLECOVATEIN [WHO-DD]

SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2), OMICRON LINEAGE XBB.1.16 (GISAID: EPI_ISL_17619088) SPIKE (S) GLYCOPROTEIN RECEPTOR BINDING DOMAIN (RBD) FRAGMENT (302-520, 1-219 IN THE CURRENT SEQUENCE), VARIANT (K 520 >G 219 ), FUSED TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2), OMICRON LINEAGE XBB.1.16 SPIKE (S) GLYCOPROTEIN RECEPTOR BINDING DOMAIN (RBD) FRAGMENT (302-520, 220-438 IN THE CURRENT SEQUENCE), SINGLE CHAIN HOMODIMER, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA

External Clinical & Regulatory Resources

Previous UNII26JN516TAT

Next UNII26K00T02NA